Trial Profile
A randomized phase II trial of adjuvant chemotherapy with UFT/LV [uracil + tegafur/folinic acid] versus S-1 following curative resection for stage III colorectal cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Jan 2019
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Folinic acid; Tegafur/uracil
- Indications Colorectal cancer
- Focus Therapeutic Use
- 01 Oct 2016 Results published in the Anticancer Research
- 26 Jan 2013 Results presented at the 2013 Gastrointestinal Cancers Symposium.
- 26 Jan 2013 Status changed from recruiting to completed.